Skip to content

Clinical trials

Completed Phase 2 Gastroesophageal Reflux trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroesophageal Reflux Phase: Phase 2 Status: Completed Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20053
20064
20073
20083
20095
20105
20123
20133
20141
20162
20172
20191
20201
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca9
Takeda5
Addex Pharma S.A.2
Eisai Inc.2
Ironwood Pharmaceuticals, Inc.2
XenoPort, Inc.2
Assistance Publique - Hôpitaux de Paris1
Columbia University1
Edusa Pharmaceuticals, Inc.1
EndoStim Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroesophageal Reflux43
Heartburn8
Asthma2
Barrett Esophagus2
Dyspepsia2
Eructation1
Esophagitis1
Esophagitis, Peptic1
Nausea1
Pain1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.